Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-label Trial to Evaluate Efficacy of Fecal Microbiota Transplantation for Treatment of Chronic Gastrointestinal Dysbiosis or Clearance of Antimicrobial Resistant Organism.

NCT03834051 is registered in ClinicalTrials.gov with Vancouver Island Health Authority as lead sponsor.

NCT NCT03834051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03834051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-label Trial to Evaluate Efficacy of Fecal Microbiota Transplantation for Treatment of Chronic Gastrointestinal Dysbiosis or Clearance of Antimicrobial Resistant Organism.
Lead sponsor
Vancouver Island Health Authority
Phase
Not applicable
Overall status
Terminated
Start date
February 1, 2019
Completion date
July 8, 2020
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antimicrobial resistant organism, dysbiosis